Valencia Technologies appoints Richard W. Klauer as Vice President of Sales to drive expansion of its innovative eCoin system for urgency urinary incontinence treatment.
 |
| Richard W Klauer, newly appointed Vice President of Sales at Valencia Technologies, to lead expansion of the eCoin system. Image: Tom Patzelt/ Valencia |
Valencia, California, USA — March 4, 2025:
Valencia Technologies has named Richard W. Klauer as its Vice President of Sales, strengthening its leadership team as it seeks to expand the commercial reach of its flagship eCoin system. The neuromodulation company, which specializes in minimally invasive treatments for urgency urinary incontinence, will benefit from Klauer’s extensive experience in urology and commercial strategy.
Bringing more than 20 years of expertise in medical device sales, Klauer has a strong track record in driving growth across various urological sub-specialties. He has played a key role in scaling early-stage companies and introducing innovative technologies that have reshaped patient care. His leadership in building and managing sales teams has positioned him as a prominent figure in the field.
In his new role, Klauer will focus on accelerating the adoption of the eCoin system, a coin-sized neurostimulator designed to alleviate symptoms of urgency urinary incontinence. Implanted under the skin near the ankle, the device delivers automatic tibial nerve stimulation twice a week through a minimally invasive procedure requiring only local anesthetic. A clinical study showed that 75% of patients experienced at least a 50% reduction in incontinence episodes within a year. Unlike many other stimulation devices, eCoin requires just one post-implant programming session and does not need weekly recharging or patient-operated controls.
Expressing enthusiasm about his appointment, Klauer highlighted the opportunity to enhance patient access to eCoin. “I am excited to continue my career in the urology space with such an innovative company as Valencia,” he said. “We look forward to expanding access to eCoin for the many physicians and patients across the country who seek another treatment option.”
Headquartered in Valencia, California, Valencia Technologies is a privately funded medical device company. It received FDA approval for the eCoin system in 2022 and aims to make the procedure widely available in physicians’ clinics.